Related Experiment Video
Updated: Mar 5, 2026
05:54
A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring
Published on: November 29, 2024
2.3K
Case Report: Pediatric Scar Management After Open-heart Surgery
Ha Phan1, Beau Harger2, Nick Estrada3
1Professional Compounding Centers of America, Houston, Texas.
International Journal of Pharmaceutical Compounding
|March 24, 2017
Summary
PracaSil-Plus, a silicone and pracaxi oil treatment, effectively improved surgical scars in a pediatric patient with tetralogy of Fallot. Scar appearance, color, stiffness, and thickness significantly reduced after 8 weeks of use.
Area of Science:
- Cardiology
- Dermatology
- Pediatric Surgery
Background:
- Tetralogy of Fallot is a congenital heart defect often requiring surgical intervention.
- Post-surgical scarring is a common concern, particularly in pediatric patients.
- Effective scar management is crucial for functional and aesthetic outcomes.
Observation:
- A case report details the use of PracaSil-Plus, a topical anhydrous silicone base with pracaxi oil, for scar management.
- The treatment was applied to a pediatric patient following open-heart surgery for Tetralogy of Fallot.
- The Patient and Observer Scar Assessment Scale (POSAS) was utilized to evaluate scar characteristics.
Findings:
- After 8 weeks of PracaSil-Plus treatment, significant improvements were noted in scar color (87.5%), stiffness (90.0%), thickness (66.7%), and irregularity (66.7%).
- The overall scar appearance improved, achieving a 77.8% reduction in the total POSAS score.
- The post-treatment scar closely resembled normal skin.
Implications:
- PracaSil-Plus demonstrates potential as an effective topical therapy for managing surgical scars in pediatric patients.
- This case report suggests PracaSil-Plus as a valuable option for healthcare providers and pharmacists involved in pediatric scar management.
- Further research may explore the broader application of PracaSil-Plus in diverse scar types and patient populations.
